What is the history of High Myopia?

TL;DR: High myopia has been documented since antiquity, with early observations by figures like Aristotle and later formal classifications by ophthalmologists in the 19th century. Today, our understanding of high myopia has shifted from a simple refractive error to a complex condition involving pathological elongation of the eyeball, now increasingly understood through advancements in genomic research and high-resolution imaging.

How was high myopia first described in medical literature?

The history of high myopia dates back to the ancient world, where philosophers like Aristotle first noted that some individuals possessed vision that required them to hold objects close to their faces. For centuries, this was simply referred to as "shortsightedness." It was not until the 19th century, with the invention of the ophthalmoscope by Hermann von Helmholtz in 1851, that physicians could finally peer into the back of the eye. This allowed researchers to distinguish between simple nearsightedness and the more dangerous, degenerative forms of high myopia, which involve thinning of the retina and choroid.

Who were the key figures in characterizing high myopia?

The German ophthalmologist Albrecht von Graefe is often credited with providing the first comprehensive clinical descriptions of the degenerative changes associated with high myopia during the mid-1800s. He identified that the condition was not merely a lens issue but involved a pathological stretching of the entire posterior segment of the eye. His work laid the foundation for recognizing that high myopia carries a significant risk of sight-threatening complications, such as retinal detachment and myopic maculopathy.

How has our understanding of high myopia evolved?

Medical understanding has transitioned from viewing high myopia as a static refractive error to recognizing it as a systemic, progressive condition. Historically, it was often misattributed to "excessive reading" or "poor posture." While environmental factors are now known to play a role, modern clinical research has corrected these misconceptions by highlighting the powerful influence of genetics. We now know that high myopia (often defined as a spherical equivalent of -6.00 diopters or worse) is frequently associated with specific genetic loci, helping researchers move toward personalized management strategies.

What are the major milestones in the study and treatment of high myopia?

The evolution of management for high myopia has progressed from basic corrective lenses to sophisticated surgical and pharmacological interventions. Key milestones include:

• 18th Century: The popularization of concave lenses to improve distance vision for those with high levels of myopia.


• 1950s-1970s: The development of scleral buckling and vitrectomy techniques, which significantly improved outcomes for retinal detachments caused by high myopia.


• 1990s-Present: The emergence of refractive surgeries, such as LASIK and PRK, followed by the adoption of low-dose atropine drops and specialized contact lenses designed to slow axial elongation in pediatric patients.


• Genetic Mapping: The identification of over 200 genetic loci associated with refractive error, providing a biological roadmap for future therapeutic interventions.

How has patient advocacy changed the landscape?

In the past, individuals with high myopia were often isolated due to the perceived "incurability" of their vision. Today, platforms like DiseaseMaps.org empower our community of 78 members living with this condition to share their experiences, fostering a sense of collective identity. Advocacy groups have been instrumental in shifting the narrative, pushing for early screening programs in schools and increased funding for research into preventing pathologic ocular elongation.

Next steps

• Consult a retina specialist or ophthalmologist for a comprehensive dilated eye exam to monitor for degenerative changes.


• Discuss current evidence-based myopia control interventions (such as orthokeratology or low-dose atropine) with your eye care provider.


• Join the DiseaseMaps.org community to connect with others who understand the day-to-day challenges of living with high myopia.


• Stay informed on the latest clinical trials through reputable registries like ClinicalTrials.gov.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Myopia.


• Online Mendelian Inheritance in Man (OMIM): Myopia, High-Grade (Entry #160700).


• Orphanet: Pathological myopia.


• International Myopia Institute: Clinical and Research Reports.